Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

tafamidis

EU orphan designation number: EU/3/12/1066   
Active ingredient: tafamidis
Indication: Treatment of senile systemic amyloidosis
Sponsor: Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2012 Orphan designation EMA/OD/115/12 (2012)8199 of 08/11/2012